Skip to search formSkip to main contentSkip to account menu

Olopatadine hydrochloride

Known as: Dibenz[B,E]Oxepin-2-Acetic Acid, 11-[3-(Dimethylamino)Propylidene]-6,11-Dihydro-, Hydrochloride, (Z)-, Hydrochloride, Olopatadine, Olopatadine Hydrochloride [Chemical/Ingredient] 
The hydrochloride salt form of olopatadine, a dual action selective histamine H1 receptor antagonist and mast cell stabilizer with anti-allergic… 
National Institutes of Health

Related topics

Related topics

20 relations
Allergic ConjunctivitisDrug AllergyHistamine H1 Receptor Antagonists [MoA]In Blood

Broader (4)

Anti-Allergic AgentsAnti-Inflammatory Agents, Non-SteroidalHistamine H1 Antagonists, Non-Sedatingolopatadine

Narrower (4)

KW 4679PATANASEPatanolPazeo

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Adequate treatment is critical for maintaining a good level of quality of life (QOL) during the pollen season in patients… 
2007
2007
Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice
Background  The skin barrier function in patients with atopic dermatitis is disrupted and prolonged topical steroid therapy… 
2007
2007
Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis.
Olopatadine hydrochloride ophthalmic solution 0.2% (Pataday, Alcon) is a new formulation of olopatadine hydrochloride ophthalmic… 
2005
2005
Efficiency of olopatadine hydrochloride 0.1% in the treatment of vernal keratoconjunctivitis and goblet cell density.
PURPOSE The aim of this study was to investigate the effect of topical 0.1% olopatadine hydrochloride on goblet cell density… 
2005
2005
Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity
Background Olopatadine hydrochloride (olopatadine; Allelock®) is one of the second‐generation antihistamines that are treated for… 
2003
2003
Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: A real-world comparison of efficacy and ocular comfort
This 3-week prospective, randomized, double-masked, parallel-group study compared ketotifen fumarate 0.025% ophthalmic solution… 
2003
2003
Evaluation of Comfort Using Olopatadine Hydrochloride 0.1% Ophthalmic Solution in the Treatment of Allergic Conjunctivitis in Contact Lens Wearers Compared to Placebo Using the Conjunctival Allergen…
Purpose. Olopatadine hydrochloride 0.1% ophthalmic solution is a topical antiallergy agent indicated for treatment of the signs… 
2002
2002
Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells.
2002
2002
Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: an open-label study.
Highly Cited
1998
Highly Cited
1998
Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)